Intravenous thrombolysis for acute ischemic stroke: The phase IV data

Journal of Stroke and Cerebrovascular Diseases

Volumn 11, Issue 3-4, 2002, Pages 137-147

  Tanne, David ^a,b,c,d   Demchuk, Andrew M ^a,b,c   Kasner, Scott E ^a,b,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cerebral ischemia; Stroke; Thrombolytic therapy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUMAZENIL; TISSUE PLASMINOGEN ACTIVATOR;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC IMAGING; HEART TAMPONADE; HEMOPERICARDIUM; HUMAN; PHASE 4 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0036589278     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2002.129959     Document Type: Article

References (63)

1. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
2. Tilley BC, Lyden PD, Brott TG, et al: Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Arch Neurol 54:1466-1474, 1997
3. Katzan IL, Furlan AJ, Lloyd LE, et al: Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 283:1151-1158, 2000
4. Broderick J, Brott T, Kothari R, et al: The Greater Cincinatti/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks. Stroke 29:415-421, 1998
5. Chiu D, Krieger D, Villar-Cordova C, et al: Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29:18-22, 1998
6. Telles JL, Kasner SE, RB, et al: Resources for acute stroke care in metropolitan Philadelphia. Ann Emerg Med 36:S35, 2000 (suppl)
7. Grond M, Stenzel C, Schmulling S, et al: Early intravenous thrombolysis for acute ischemic stroke in community-based approach. Stroke 29:1544-1549, 1998
8. Hill MD, Barber PA, Demchuk AM, et al: Building a brain attack team to administer thrombolytic therapy for acute ischemic stroke. Canadian Med Assoc J 162:1589-1593, 2000
9. Marler JR, Jones PW, Emr M: Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda, MD, The National Institute of Neurological Disorders and Stroke, National Institutes of Health, 1997. Available at http://www.ninds.nih.gov/health.and.medical/stroke.proceedings/titlepage.htm
10. Alberts MJ, Hademenos G, Latchaw RE, et al: Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 283:3102-3109, 2000
11. Fagan SC, Morgenstern LB, Petitta A, et al: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 50:883-890, 1998
12. Wang DZ, Rose JA, Honings DS, et al: Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke 31:77-81, 2000
13. Goldstein LB, Hey LA, Laney R: North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services. Stroke 31:66-70, 2000
14. Scott PA, Temovsky CJ, Lawrence K, et al: Analysis of Canadian population with potential geographic access to intravenous thrombolysis for acute ischemic stroke. Stroke 29:2304-2310, 1998
15. Silliman SL, Riley P, Huggett V, et al: Helicopter transport expands the availability of thrombolytic therapy to residents of rural areas. Stroke 30:263, 1999 (abstract)
16. Conroy MB, Rodriguez SU, Kimmel SE, et al: Helicopter transfer offers a potential benefit to patients with acute stroke. Stroke 30:2580-2584, 1999
17. Chalela JA, Kasner SE, Jauch EC, et al: Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke 30:2366-2368, 1999
18. Levine SR, Gorman M: Telestroke: The application of telemedicine for stroke. Stroke 30:464-469, 1999
19. Bates V, Kamran S, Empy H: To describe the use of telemedicine in acute stroke treatment. Neurology 52:A363, 1999 (abstr)
20. Lamonte MP, Xiao Y, Mackenzie CF, et al: Tele-BAT: Mobile telemedicine for the Brain Attack Team. Stroke 29:312, 1998 (abstr)
21. Marler J, Tilley BC, Lu M, et al: Early stroke treatment associated with better outcome. The NINDS rt-PA Stroke Study. Neurology 55:1649-1655, 2000
22. Tanne D, Bates VE, Verro P, et al: Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey. The t-PA Stroke Survey Group. Neurology 53:424-427, 1999
23. Hill MD, Woolfendeu A, Teal PA, et al: Intravenous Alteplase for Stroke: The Canadian experience. The Stroke Interventionalist 2:3-8, 2000
24. Kanter D, Kothari R, Pancioli A, et al: The greater Cincinnati t-PA experience after the NINDS trial: Does a longer time to treatment within the current three-hour window reduce efficacy? Stroke 30:244, 1999 (abstr)
25. Hanson SK, Brauer DJ, Brown RD, et al: Should use of t-PA for ischemic stroke be restricted to specialized stroke centers. Stroke 31:313, 2000 (abstr)
26. Buchan AM, Barber PA, Newcommon N, et al: Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness. Neurology 54:679-684, 2000
27. Albers GW, Bates VE, Clark WM, et al: Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145-1150, 2000
28. Schmadulling S, Grond M, Rudolf J, et al: One-year follow-up in acute stroke patients treated with rtPA in clinical routine. Stroke 31:1552-1554, 2000
29. Buggle F, Grau AJ, Spranger M, et al: Routine use of thrombolysis: Experienced centers report better outcome. Stroke 30:265, 1999 (abstr)
30. Lopez-Yunez AM, Bruno A, Zurru C, et al: Protocol violations in community-based rt-PA use are associated with symptomatic intracerebral hemorrhage. Stroke 30:264, 1999 (abstr)
31. Demchuk AM, Morgenstern LB, Krieger DW, et al: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 30:33-39, 1999
32. Tanne D, Kasner SE, Demchuk AM, et al: Prediction of Intracerebral Hemorrhage After Intravenous rt-PA Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter Acute Stroke Survey. (submitted)
33. Demchuk AM, Tanne D, Hill MD, et al: Predictors of good outcome after intravenous rt-PA for acute ischemic stroke: The multicentre acute stroke survey. Neurology (in press)
34. Tanne D, Gorman MJ, Bates VE, et al: Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: The tPA stroke survey experience. Stroke 31:370-375, 2000
35. Grond M, Rudolf J, Schmulling S, et al: Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke. Arch Neurol 55:466-469, 1998
36. Kasner SE, Villar-Cordova CE, Tong D, et al: Hemopericardium and cardiac tamponade after thrombolysis for acute ischemic stroke. Neurology 50:1857-1859, 1998
37. Hill MD, Barber PA, Takahashi J, et al: Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. Canadian Med Assoc J 162:1281-1284, 2000.
38. Rudolf J, Grond M, Schmulling S, et al: Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase. Neurology 55:599-600, 2000
39. Rudolf J, Grond M, Prince WS, et al: Evidence of anaphylaxy after alteplase infusion. Stroke 30:1142-1143, 1999
40. The NINDS rt-PA Stroke Study Group: Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 28:2119-2125, 1997
41. Caplan LR, Mohr JP, Kistler JP, et al: Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis - Not a panacea for ischemic stroke. N Engl J Med 337:1309-1310, 1997
42. del Zoppo GJ, Poeck K, Pessin MS, et al: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78-86, 1992
43. von Kummer R, Allen KL, Holle R, et al: Acute stroke: Usefulness of early CT findings before thrombolytic therapy. Radiology 205:327-333, 1997
44. Pressman BD, Tourje EJ, Thompson JR: An early CT sign of ischemic infarction: Increased density in a cerebral artery. Am J Radiol 149:583-586, 1987
45. von Kummer R, Hacke W, Meier D: The extent of ischemic brain edema and the response to rt-PA in ECASS II. Stroke 30:250, 1999
46. Schriger DL, Kalafut M, Starkman S, et al: Cranial computed tomography interpretation in acute stroke: Physician accuracy in determining eligibility for thrombolytic therapy. JAMA 279:1293-1297, 1998
47. Grotta JC, Chiu D, Lu M, et al: Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rt-PA therapy. Stroke 30:1528-1533, 1999
48. Wardlaw JM, Dorman PJ, Lewis SC, et al: Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT? J Neurol Psych 67:651-653, 1999
49. Lansberg MG, Albers GW, Beaulieu C, et al: Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 54:1557-1561, 2000
50. Barber PA, Demchuk AM, Zhang J, et al: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355:1670-1674, 2000
51. Bastianello S, Pierallini A, Colonnese C, et al: Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 33:207-211, 1991
52. Schuknecht B, Ratzka M, Hoffmann E: The dense artery sign - Major cerebral artery thromboembolism demonstrated by computed tomography. Neuroradiology 32:98-103, 1990
53. Rauch RA, Bazan CD, Larsson EM, et al: Hyperdense middle cerebral arteries identified on CT as a false sign of vascular occlusion. Am J Neuroradiol 14:669-673, 1993
54. Manelfe C, Larrue V, von Kummer R, et al: Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30:769-672, 1999
55. Demchuk AM, Felburg RA, Alexandrov AV: Clinical recovery from acute ischemic stroke after early reperfusion of the brain with intravenous thrombolysis. N Engl J Med 340:894-895, 1999 (letter)
56. Bendszus M, Urbach H, Ries F, et al: Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 40:54-58, 1998
57. Barber PA, Demchuk AM, Hudon ME: The hyperdense sylvian fissure MCA "dot" sign. A CT marker of acute ischemia. Stroke 32:84-88, 2001
58. Shrier DA, Tanaka H, Numaguchi Y, et al: CT angiography in the evaluation of acute stroke. Am J Neuroradiol 18:1011-1020, 1997.
59. Knauth M, von Kummer R, Jansen O, et al: Potential of CT angiography in acute ischemic stroke. Am J Neuroradiol 18:1001-1010, 1997
60. Wildermuth S, Knauth M, Brandt T, et al: Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 29:935-938, 1998
61. Lee KH, Lee SJ, Cho SJ, et al: Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Arch Neurol 57:1000-1008, 2000
62. Kaps M, Link A: Transcranial sonographic monitoring during thrombolytic therapy. Am J Neuroradiol 19:758-760, 1998
63. Burgin WS, Malkoff M, Felberg RA, et al: Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke 31:1128-1132, 2000